New Key Statistics Module, Z-Score and F-Score
NYSE:GMED Key Ratios
Market Cap $ M | 6,818.71 |
Enterprise Value $ M | 6,966.17 |
P/E(ttm) | 43.05 |
PE Ratio without NRI | 22.33 |
Forward PE Ratio | 19.18 |
Price/Book | 1.72 |
Price/Sales | 3.87 |
Price/Free Cash Flow | 37.55 |
Price/Owner Earnings | 220.73 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1,568.00 |
EPS (TTM) $ | 1.17 |
Beneish M-Score | -1.81 |
10-y EBITDA Growth Rate % | 6.60 |
5-y EBITDA Growth Rate % | 8.60 |
y-y EBITDA Growth Rate % | 1.90 |
EV-to-EBIT | 34.51 |
EV-to-EBITDA | 20.10 |
PEG | 2.60 |
Shares Outstanding M | 135.37 |
Net Margin (%) | 7.83 |
Operating Margin % | 12.87 |
Pre-tax Margin (%) | 10.55 |
Quick Ratio | 2.72 |
Current Ratio | 4.88 |
ROA % (ttm) | 3.64 |
ROE % (ttm) | 4.41 |
ROIC % (ttm) | 5.47 |
Dividend Yield % | -- |
Altman Z-Score | 4.93 |
GMED Number of Guru Trades
GMED Volume of Guru Trades
Gurus Latest Trades with NYSE:GMED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:GMED is held by these investors
Total 3
Globus Medical Inc Insider Transactions
No Available Data
News about NYSE:GMED
Total 0- 1